Life Sciences Insights

Conceptual pharmaceutical packaging partner evaluation with a vial, blister pack, and blank carton

How to Choose a Pharmaceutical Packaging Partner

Before comparing quotes, decide what you want a pharmaceutical packaging partner to own. Materials, packaging operations, artwork, data, and delivery should not sit inside one vague promise of end-to-end suppor...

Conceptual CDMO capacity planning illustration with pharmaceutical production equipment, vials, and planning documents

CDMO Capacity Planning: Questions Sponsors Should Ask Before Signing

A production date is not a complete supply plan. Before signing, use CDMO capacity planning to ask what is reserved, what must be ready, and when usable product is expected. Ask each finalist to work from the s...

Pharmaceutical analytical testing labs illustrated with unbranded instruments, sample vials, and document folders

How to Select a Pharmaceutical Analytical Testing Laboratory

A laboratory’s service list is not your project plan. When comparing pharmaceutical analytical testing labs, start with the work you need done, the evidence you need back, and the decision those results must su...

Conceptual glass vials and manufacturing enclosure for sterile fill-finish CDMO selection

Sterile Fill-Finish CDMO Selection: Capabilities, Risk and Quality Factors

A sterile fill finish CDMO should be judged against your product brief, not its longest equipment list. Start by asking which site and line would handle your work, what evidence supports that fit, and who owns ...

Conceptual illustration of evaluating cell and gene therapy CDMOs, with manufacturing equipment and sample containers

Cell and Gene Therapy CDMOs: How to Evaluate Specialized Manufacturing Partners

A polished capabilities deck is not a manufacturing plan. When evaluating cell and gene therapy CDMOs, start with the work your program needs, the evidence behind each capability, and the people who will own de...

Conceptual manufacturing partner comparison for a US vs Europe CDMO decision

U.S. vs European CDMOs: How to Compare Manufacturing Partners

A US vs Europe CDMO comparison should start with the work your product needs, not a regional winner. Compare named manufacturing sites against the same scope, deadline, and supply plan. For CEOs and life-scienc...

Conceptual CDMO technology transfer handoff between two unbranded manufacturing facilities

CDMO Technology Transfer: How to Reduce Risk When Moving a Process

Before moving a pharmaceutical or biotech process, ask a plain question: what must the receiving team know, do, and show before you accept the handoff? CDMO technology transfer deserves that level of detail—not...

Conceptual conference-planning table, notebooks and molecular models for life sciences, pharma and CDMO events

Life Sciences, Pharma & CDMO Conferences 2026–2027

Conference calendars get crowded long before teams decide what they want from them. This guide to life sciences pharma cdmo conferences 2026 2027 helps leaders build a defensible shortlist without relying on st...

Conceptual biopharma manufacturing and meeting artwork for the ISPE Pharma 4.0 conference buyer guide

ISPE Pharma 4.0 & Biopharma Conference: 2026 Event Guide

A conference trip needs a business case, not just a badge. The ISPE Pharma 4.0 & Biopharma Conference 2026 is a chance to assess whether your team's manufacturing, technology, or commercial questions ju...

Abstract chromatography bead illustration for a Capto Core 700 multimodal chromatography resin buyer guide

Capto Core 700 Multimodal Chromatography Resin: A Buyer Guide

A purchase decision for Capto Core 700 should begin with the intended separation task, not a catalog listing. This guide to Capto Core 700 multimodal chromatography resin helps business and marketing leaders or...